EU regulators start review of China’s Sinovac vaccine

Researchers unveil first molecular images of B.1.1.7 COVID-19 mutation
4 May 2021
Little to no increase in association between adolescents’ mental health problems and digital tech
4 May 2021

EU regulators start review of China’s Sinovac vaccine

The European Union’s drug regulator announced Tuesday that it has started a rolling review of China’s Sinovac coronavirus vaccine to assess its effectiveness and safety, a first step toward possible approval for use in the 27-nation bloc.

Comments are closed.